glp-1 receptor agonists should be avoided in patients with The Potential Indirect Impact of the Management of Fibromyalgia Glucagon-like peptide-1 receptor agonists and

Interestingly, certain bitter compounds, such as denatonium benzoate (DB), have been found to stimulate the secretion of insulin, glucagon, somatostatin, and GLP-1 from pancreatic islets independently of glucose levels

Beneficial Consequences of GLP-1RA Effects on Gastric Emptying Reduction in Postmeal Glycemic Excursions Elevation of postprandial glycemia (PPG) is characteristically the initial defect in glucose intolerance (1) and is a challenging aspect of the management of T2D (2)

doi: 10.1016/S2213-8587(21)00203-5 31 HtikeZZZaccardiFPapamargaritisDWebbDRKhuntiKDaviesMJ

Coming from low-dose semaglutide or tirzepatide

The risk vs benefit of these agents should be considered before prescribing these drugs to patients at risk for CHF

macrophage and monocyte activation by oxidised low-density lipoprotein